Precision medicine

Clinical trials in lung cancer and mesothelioma

The TOGA clinical trial and research program spans early and advanced non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), mesothelioma, other thymic malignancies, supportive & palliative care and translational research. Successful collaborations for clinical trials have been established within Australia and in North America, Asia and Europe. TOGA has a long-standing collaboration with the National Health and Medical Research Council Clinical Trials Centre (NHMRC CTC) that has provided exemplary conduct of their clinical trials both locally, and internationally.

Research Development

Clinical trials open to recruitment

Clinical trials in follow up

Endorsed clinical trials

TOGA acknowledges the Traditional Custodians of the land, pays respect to elders past, present and emerging, and extends that respect to all indigenous people.

PO Box 4002


St Leonards, NSW, 2065

Ph: +61 3 9087 3550

ABN: 47 641 984 198

registered charity

Thoracic Oncology Group of Australasia is registered with the Australian Taxation Office as an Income Tax Exempt Charitable Entity. Donations $2 and over are tax deductible.